[{"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-001", "question": "A 68-year-old man with a history of severe aortic stenosis (mean gradient 48 mmHg, AVA 0.7 cm²) presents with decompensated heart failure. He is hypotensive (85/50 mmHg) and hypoxic despite high-flow oxygen. Transthoracic echocardiography shows a hyperdynamic left ventricle with near-cavity obliteration, severe mitral regurgitation (new, eccentric posteriorly directed jet), and systolic anterior motion of the mitral valve with LVOT obstruction (peak gradient 120 mmHg). Which of the following is the single most appropriate immediate pharmacologic intervention?", "options": ["Intravenous phenylephrine infusion", "Intravenous esmolol infusion", "Intravenous nitroglycerin infusion", "Intravenous furosemide bolus", "Intravenous milrinone infusion"], "answer": "A", "answer_index": 0, "explanation": "This patient has severe aortic stenosis with a dynamic LVOT obstruction (systolic anterior motion) precipitated by hypovolemia and hypercontractility, leading to hypotension and secondary mitral regurgitation. Phenylephrine, an alpha-agonist, increases afterload and blood pressure, which reduces the LVOT gradient and improves forward flow. Esmolol (negative inotrope) could worsen heart failure in the setting of severe AS. Nitroglycerin and furosemide reduce preload, exacerbating the obstruction. Milrinone is a positive inotrope and vasodilator, which would dramatically worsen the LVOT gradient and hypotension.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "The patient has severe aortic stenosis with decompensated heart failure, but the acute presentation shows **dynamic LVOT obstruction** due to systolic anterior motion (SAM) of the mitral valve, causing a high LVOT gradient (120 mmHg) and severe mitral regurgitation.  \n\nIn this setting, the LV is hyperdynamic and underfilled, leading to hypotension and hypoxia. The priority is to **increase afterload** to reduce the LVOT gradient, **increase preload**, and avoid inotropes or vasodilators, which would worsen obstruction.  \n\n- **Phenylephrine** (A) is an α‑1 agonist that increases systemic vascular resistance and blood pressure, which can reduce the dynamic LVOT gradient and improve forward flow.  \n- Esmolol (B) is a β‑blocker that can reduce contractility and heart rate, which is useful in chronic hypertrophic cardiomyopathy with obstruction, but in this acute, hypotensive, hypoxic setting, it could worsen hypotension and is not first‑line.  \n- Nitroglycerin (C) and furosemide (D) reduce preload and afterload, worsening the obstruction and hypotension.  \n- Milrinone (E) is an inotrope and vasodilator, which would exacerbate the LVOT gradient and hypotension.  \n\nThe most appropriate immediate pharmacologic intervention is **intravenous phenylephrine**.  \n\n**The answer is (A)**"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-002", "question": "A 3-day-old full-term neonate, born via uncomplicated vaginal delivery, is noted to have progressive tachypnea, grunting, and hypoxemia requiring 60% FiO2. Chest X-ray shows diffuse granular opacities with air bronchograms. Surfactant administration provides minimal improvement. Echocardiogram shows normal cardiac anatomy, but there is severe pulmonary hypertension with suprasystemic right ventricular pressures and right-to-left shunting across a patent foramen ovale. Which of the following underlying conditions is the most likely cause of this refractory pulmonary hypertension of the newborn?", "options": ["Congenital alveolar capillary dysplasia", "Meconium aspiration syndrome", "Transient tachypnea of the newborn", "Group B streptococcal pneumonia", "Idiopathic respiratory distress syndrome"], "answer": "A", "answer_index": 0, "explanation": "Congenital alveolar capillary dysplasia (ACD) with misalignment of pulmonary veins is a rare, lethal lung developmental disorder that presents identically to severe persistent pulmonary hypertension of the newborn (PPHN) but is completely refractory to all standard therapies, including surfactant, inhaled nitric oxide, and ECMO. The history of a full-term infant with rapid progression and lack of response to surfactant is classic. Meconium aspiration and sepsis can cause severe PPHN but typically show some response to aggressive management. Transient tachypnea and idiopathic RDS are not associated with such severe, immediate refractory pulmonary hypertension.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "The clinical picture is a term neonate with severe, refractory hypoxemia due to pulmonary hypertension that does not respond to surfactant.  \nThe chest X-ray findings are similar to respiratory distress syndrome (RDS), but surfactant therapy fails, which is unusual for classic RDS in a term infant.  \nSevere, persistent pulmonary hypertension of the newborn (PPHN) that is unresponsive to usual therapies (including surfactant and oxygen) in a term infant should raise suspicion for a developmental lung disorder such as alveolar capillary dysplasia (ACD), often associated with misalignment of pulmonary veins.  \nThis condition is typically fatal without lung transplantation and presents with refractory PPHN.  \n\nThe other options:  \n- **B. Meconium aspiration syndrome** – usually improves with surfactant, nitric oxide, and support; not typically completely refractory from day 1 with a diffuse granular CXR.  \n- **C. Transient tachypnea of the newborn** – improves with time and oxygen, not associated with severe refractory PPHN.  \n- **D. Group B streptococcal pneumonia** – can cause PPHN but usually has other signs (hypotension, infiltrates) and may respond to antibiotics and support; CXR not typically diffuse granular like RDS.  \n- **E. Idiopathic respiratory distress syndrome** – mainly in preterms, surfactant should provide some improvement.  \n\nGiven the refractoriness and severity, **A** is the most likely.  \n\nThe answer is A"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-003", "question": "A 42-year-old woman is brought to the ED after a high-speed motor vehicle collision. Primary survey reveals a Glasgow Coma Scale of 14, heart rate 130 bpm, BP 88/50 mmHg, and SpO2 94% on room air. Focused Assessment with Sonography for Trauma (FAST) is positive for fluid in the hepatorenal recess. After initiating a massive transfusion protocol, her blood pressure transiently improves with crystalloid, then drops again. Bedside ultrasound now shows a new, large pericardial effusion with diastolic right ventricular collapse. Which of the following is the most appropriate immediate procedural intervention?", "options": ["Emergency department thoracotomy", "Pericardiocentesis via subxiphoid approach", "Left anterolateral tube thoracostomy", "Right tube thoracostomy", "Laparotomy with aortic cross-clamping"], "answer": "B", "answer_index": 1, "explanation": "The patient has developed cardiac tamponade (evidenced by diastolic RV collapse on ultrasound) in the context of trauma and a positive FAST exam, suggesting concurrent intra-abdominal hemorrhage. In blunt trauma, the cause is likely myocardial rupture or coronary vessel injury. Pericardiocentesis is the immediate life-saving procedure to relieve tamponade while simultaneously preparing for definitive operative management. ED thoracotomy is indicated for penetrating trauma with recent loss of signs of life. Tube thoracostomy addresses hemothorax, not pericardial tamponade. Laparotomy addresses the abdominal hemorrhage but would not relieve the cardiac tamponade, and the patient would likely arrest on induction of anesthesia.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The patient has signs of hemorrhagic shock with a positive FAST for intra-abdominal fluid, but the new finding of a pericardial effusion with diastolic right ventricular collapse indicates cardiac tamponade.  \nIn trauma, pericardial tamponade can result from penetrating or blunt injury and requires immediate decompression.  \nPericardiocentesis (often ultrasound-guided) can be performed emergently in the ED as a temporizing measure to relieve tamponade while preparing for definitive surgical repair.  \nEmergency department thoracotomy is not indicated here because the patient still has a pulse and some blood pressure.  \nTube thoracostomy would not address pericardial tamponade.  \nLaparotomy would address the abdominal bleeding but not the immediate life-threatening tamponade.  \n\nThe answer is B"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-004", "question": "A 28-year-old woman presents with a 6-month history of symmetric inflammatory polyarthritis affecting her wrists, MCPs, and knees, morning stiffness >1 hour, and a new facial rash. Labs show ANA 1:1280 (speckled), anti-dsDNA negative, anti-Smith positive, anti-RNP positive, complement levels normal, and urinalysis with 2+ protein but no cellular casts. She is started on hydroxychloroquine. Two weeks later, she develops acute dyspnea, pleuritic chest pain, and hypoxia. CT pulmonary angiography shows no pulmonary embolism but reveals extensive bilateral ground-glass opacities and pleural effusions. Which of the following is the most likely diagnosis?", "options": ["Lupus pneumonitis", "Drug reaction to hydroxychloroquine", "Acute pulmonary hemorrhage from vasculitis", "Pulmonary hypertension due to SLE", "Opportunistic infection due to immunosuppression"], "answer": "A", "answer_index": 0, "explanation": "The patient has SLE (meeting criteria with arthritis, malar rash, anti-Smith positivity). The acute respiratory presentation with ground-glass opacities and pleural effusions in this context is most consistent with acute lupus pneumonitis, a rare but severe manifestation of SLE. Timing makes drug reaction unlikely, as hydroxychloroquine toxicity is typically chronic and not acute pulmonary. Pulmonary hemorrhage would show falling hematocrit and more alveolar filling. Pulmonary hypertension is a chronic process. Opportunistic infection is improbable given the very short course of a minimally immunosuppressive agent (hydroxychloroquine).", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "The patient has SLE based on clinical and serologic criteria (arthritis, rash, positive ANA, anti-Smith positive).  \nAcute onset of dyspnea, pleuritic pain, hypoxia, and CT findings of bilateral ground-glass opacities with pleural effusions in an SLE patient, soon after starting hydroxychloroquine, raises suspicion for **lupus pneumonitis** — an acute inflammatory lung manifestation of SLE.  \n\nHydroxychloroquine toxicity is rare and usually not this acute; pulmonary hemorrhage would typically show more dramatic hemorrhage on imaging; pulmonary hypertension is usually subacute and not with ground-glass opacities like this; opportunistic infection is less likely given only recent start of hydroxychloroquine without other immunosuppressants.  \n\nThe answer is A.  \n\nThe answer is (A)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-005", "question": "A 55-year-old man with a history of MEN1 syndrome (previous parathyroidectomy, pancreatic neuroendocrine tumor resection) presents with profound hypoglycemia (glucose 38 mg/dL) and inappropriately elevated serum insulin and C-peptide during a supervised fast. Localizing studies, including endoscopic ultrasound and Ga-68 DOTATATE PET/CT, show no identifiable pancreatic lesion. Which of the following is the most appropriate next step in management?", "options": ["Empiric distal pancreatectomy", "Initiation of diazoxide therapy", "Selective arterial calcium stimulation with hepatic venous sampling", "Empiric total pancreatectomy", "Long-acting somatostatin analog therapy (e.g., lanreotide)"], "answer": "C", "answer_index": 2, "explanation": "In a patient with MEN1 and biochemically proven endogenous hyperinsulinemic hypoglycemia (insulinoma) with negative conventional and advanced imaging, the next step is selective arterial calcium stimulation (SACS) with hepatic venous sampling. This invasive angiographic procedure can regionalize the source of insulin secretion to a specific pancreatic arterial territory (gastroduodenal, superior mesenteric, or splenic arteries), guiding targeted surgical exploration. Empiric distal or total pancreatectomy carries high morbidity and may miss the lesion. Diazoxide and somatostatin analogs are temporizing medical therapies but do not address the need for definitive localization and resection in a surgical candidate.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The patient has MEN1 syndrome with biochemical evidence of endogenous hyperinsulinemic hypoglycemia (insulinoma) but no identifiable lesion on imaging, including sensitive modalities like Ga-68 DOTATATE PET/CT.  \nIn this scenario, when noninvasive imaging fails to localize an insulinoma, the next step is **invasive localization** before surgery.  \nSelective arterial calcium stimulation (SACST) with hepatic venous sampling can help regionalize the source of insulin hypersecretion within the pancreas and is particularly useful in MEN1 patients who may have multiple small tumors.  \n\nEmpiric surgery (A or D) without localization is not appropriate.  \nDiazoxide (B) or somatostatin analogs (E) are medical management options but are usually reserved for controlling symptoms when surgery is delayed or not possible, but localization should be attempted first if curative resection is the goal.  \n\nThe most appropriate next step is **Selective arterial calcium stimulation with hepatic venous sampling** to guide targeted surgical resection.  \n\nThe answer is C"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-006", "question": "A 7-year-old boy is evaluated for short stature. He has a history of congenital hypothyroidism diagnosed on newborn screening, treated with levothyroxine. Growth chart shows length and weight at the 5th percentile at birth, falling to below the 1st percentile by age 3. Current bone age is delayed by 3 years. Physical exam reveals a prominent forehead, depressed nasal bridge, and small hands with brachydactyly. Labs show normal TSH and free T4 on replacement. Which of the following genetic mutations is most likely responsible for this clinical picture?", "options": ["SHOX gene mutation", "GH1 gene mutation (isolated GH deficiency)", "GNAS1 gene mutation (Albright hereditary osteodystrophy)", "PROP1 gene mutation (combined pituitary hormone deficiency)", "FGFR3 gene mutation (achondroplasia)"], "answer": "D", "answer_index": 3, "explanation": "The combination of congenital hypothyroidism, severe postnatal growth failure with delayed bone age, and mild facial dysmorphism is classic for combined pituitary hormone deficiency (CPHD) due to a PROP1 mutation. PROP1 is a pituitary transcription factor critical for the development of somatotrophs, lactotrophs, thyrotrophs, and gonadotrophs. Deficiency presents with growth hormone, TSH, and later gonadotropin deficiencies. The congenital hypothyroidism was central (pituitary), not primary thyroidal. SHOX mutations cause Leri-Weill dyschondrosteosis. GNAS1 mutations cause pseudohypoparathyroidism with specific skeletal findings (brachydactyly type E). Isolated GH deficiency or achondroplasia would not explain the central hypothyroidism.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The patient has a history of congenital hypothyroidism but is now euthyroid on replacement.  \nHe has disproportionate short stature (small hands, brachydactyly), facial features (prominent forehead, depressed nasal bridge), and delayed bone age.  \nThese features, along with a history of congenital hypothyroidism, point toward **Albright hereditary osteodystrophy** (pseudohypoparathyroidism type 1a), caused by **GNAS1 mutation**, which can include multihormone resistance (TSH, PTH) and characteristic skeletal findings (brachydactyly, short stature, round face, delayed bone age).  \n\nThe answer is C"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-007", "question": "A 70-year-old man with severe, calcific aortic stenosis (AVA 0.6 cm², mean gradient 55 mmHg) and chronic kidney disease (eGFR 28 mL/min/1.73m²) presents with recurrent hospitalizations for heart failure with preserved ejection fraction (LVEF 65%). He is deemed high-risk for surgical AVR. He undergoes transcatheter aortic valve implantation (TAVI) with a balloon-expandable valve. Immediately post-deployment, transesophageal echocardiography shows a well-seated valve with mild paravalvular leak, mean gradient 8 mmHg, and new severe mitral regurgitation with a wide vena contracta and eccentric anteriorly directed jet. The left ventricular systolic function appears hyperdynamic. What is the most likely mechanism of the acute severe mitral regurgitation?", "options": ["Iatrogenic injury to the mitral valve apparatus from the delivery system", "Dynamic left ventricular outflow tract obstruction causing systolic anterior motion of the mitral valve", "Unmasking of pre-existing severe ischemic mitral regurgitation due to afterload reduction", "Valve prosthesis impingement on the anterior mitral leaflet", "Acute papillary muscle dysfunction due to coronary occlusion"], "answer": "B", "answer_index": 1, "explanation": "In a patient with severe AS and a small, hypertrophied, hyperdynamic left ventricle, relief of the afterload obstruction via TAVI can precipitate dynamic LVOT obstruction. This leads to systolic anterior motion (SAM) of the mitral valve, causing acute, severe mitral regurgitation with an eccentric anterior jet. This is a recognized complication of TAVI, particularly in patients with certain anatomical predictors (septal hypertrophy, small LV cavity). Direct injury from the delivery system is rare. Pre-existing severe MR would have been evident pre-procedure. Prosthetic impingement typically causes central MR. Coronary occlusion is possible but would more likely cause regional wall motion abnormalities and ischemic MR.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The patient has severe aortic stenosis with a small aortic valve area and high gradient, and after TAVI, the gradient drops dramatically (to 8 mmHg).  \nNew severe mitral regurgitation with an **eccentric anteriorly directed jet** and **hyperdynamic LV** post-TAVI suggests systolic anterior motion (SAM) of the mitral valve.  \nSAM occurs when the anterior mitral leaflet is pulled into the LVOT during systole, often due to hyperdynamic function and reduced afterload, which is common after relief of aortic stenosis.  \nThis fits the scenario better than mechanical impingement (which might cause a different jet direction) or acute coronary occlusion (no mention of ischemia).  \n\n**The answer is B**"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-008", "question": "A 4-week-old male infant is admitted with a 2-day history of poor feeding, lethargy, and vomiting. He was born at term, breastfeeding well until this illness. Vital signs: T 36.8°C, HR 180 bpm, RR 65/min, BP 65/40 mmHg, SpO2 98% room air. He is mottled, with delayed capillary refill. Laboratory studies show: Na 125 mEq/L, K 8.9 mEq/L, Cl 94 mEq/L, CO2 14 mEq/L, glucose 48 mg/dL, Ca 9.8 mg/dL. Point-of-care cortisol is 2 mcg/dL (drawn prior to any steroid administration). Which of the following is the most urgent diagnostic test to confirm the underlying etiology?", "options": ["Plasma renin activity and aldosterone level", "Karyotype analysis", "Serum 17-hydroxyprogesterone level", "ACTH stimulation test", "Urine organic acid analysis"], "answer": "C", "answer_index": 2, "explanation": "The infant presents in acute adrenal crisis with profound hyponatremia, hyperkalemia, hypoglycemia, and low cortisol, diagnostic of primary adrenal insufficiency. The most common cause in a male infant is congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, which is detected by a markedly elevated serum 17-hydroxyprogesterone level. This is the most urgent specific diagnostic test, as it guides definitive management and genetic counseling. Plasma renin activity will be elevated, but does not specify the etiology. Karyotype is not urgent; males with CAH have a 46,XY karyotype. An ACTH stimulation test is diagnostic for adrenal insufficiency but is contraindicated in acute crisis and does not identify the specific enzyme defect. Urine organic acids help diagnose other metabolic disorders.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The presentation suggests salt-wasting congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, with hyponatremia, hyperkalemia, hypoglycemia, and low cortisol. The most urgent confirmatory test in this acute setting is **serum 17-hydroxyprogesterone**, which is markedly elevated in 21-hydroxylase deficiency and provides a rapid diagnosis.  \n\nThe answer is C"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-009", "question": "A 32-year-old woman with a history of systemic sclerosis (limited cutaneous variant, anti-centromere positive) presents to the rheumatology clinic for routine follow-up. She reports excellent control of her Raynaud's phenomenon and stable skin disease. She has no cardiac or renal symptoms. Her vital signs are normal. A screening transthoracic echocardiogram is performed, which reveals normal left and right ventricular size and function, but there is a small to moderate pericardial effusion. Which of the following findings on echocardiogram would be the strongest indicator to initiate specific pharmacologic therapy directed at the effusion?", "options": ["Right atrial diastolic collapse", "Respiratory variation in mitral inflow velocity >25%", "Inferior vena cava plethora with <50% collapse on sniff", "Swinging heart motion", "Left atrial compression during systole"], "answer": "C", "answer_index": 2, "explanation": "In a patient with a chronic, stable effusion (like those common in connective tissue diseases), the strongest echocardiographic sign of hemodynamic compromise (tamponade physiology) is inferior vena cava (IVC) plethora with minimal respiratory collapse (<50%). This indicates elevated right atrial pressure. In chronic effusions, the chambers have had time to adapt, so classic signs like right atrial collapse may be absent or late. Respiratory variation in mitral inflow (>25%) is a sensitive sign but can be seen in other conditions like COPD. Right atrial collapse is an early sign but less specific in chronic settings. Swinging heart is seen with very large effusions but not specific for tamponade. Left atrial compression is rare.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The question asks for the strongest indicator to initiate specific pharmacologic therapy for a pericardial effusion in a patient with systemic sclerosis.  \nThe key is to identify signs of **cardiac tamponade** or hemodynamic compromise, which would warrant intervention.  \n\n- **Right atrial diastolic collapse** is an early sign of tamponade but may not be the most specific or strongest in isolation.  \n- **Respiratory variation in mitral inflow velocity >25%** (indicating pulsus paradoxus on Doppler) is a sensitive marker of hemodynamic compromise in tamponade.  \n- **Inferior vena cava plethora with <50% collapse on sniff** suggests elevated right atrial pressure, which can occur with tamponade but is also seen in other conditions like heart failure.  \n- **Swinging heart motion** is a visual finding in large effusions but not a direct indicator of hemodynamic compromise.  \n- **Left atrial compression during systole** is less common and not a typical primary criterion for intervention.  \n\nIn clinical guidelines and echocardiography assessment for tamponade, **respiratory variation >25% in mitral inflow** (or similar in other valves) is a strong Doppler indicator of hemodynamically significant effusion requiring therapy.  \n\nThe answer is **B**.  \n\nThe answer is (B)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-010", "question": "A 16-year-old girl is brought to the ED after collapsing during her high school soccer game. She was pulseless and apneic but received immediate bystander CPR and was defibrillated once with ROSC after 4 minutes. Her initial ECG in the ED shows sinus rhythm with diffuse ST-segment elevation in precordial leads V1-V4 and inferior leads II, III, aVF. Bedside echocardiogram shows severe hypokinesis of the mid to apical left ventricle with hypercontractility of the basal segments. Troponin I is elevated at 15 ng/mL. Which of the following is the most critical next step in management to prevent recurrence?", "options": ["Immediate coronary angiography", "Initiation of an intravenous beta-blocker", "Insertion of a wearable cardioverter-defibrillator", "Initiation of intravenous immunoglobulin (IVIG)", "Administration of intravenous calcium gluconate"], "answer": "B", "answer_index": 1, "explanation": "The clinical presentation and echocardiographic findings are classic for Takotsubo (stress) cardiomyopathy, which can rarely present with ventricular fibrillation arrest. The ECG can mimic STEMI. The most critical step to prevent recurrence of malignant arrhythmias in the acute phase is suppression of catecholamine-driven triggered activity with an intravenous beta-blocker. Immediate coronary angiography is often performed to rule out acute coronary syndrome, but the typical regional wall motion abnormality (apical ballooning) and clinical context make it less likely to be the immediate preventive measure for recurrence. ICD implantation is not indicated in the acute phase of a reversible cardiomyopathy. IVIG is for myocarditis. Calcium is for hyperkalemia or calcium channel blocker overdose.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The patient’s presentation — sudden cardiac arrest in a young athlete, ECG with diffuse ST elevation, elevated troponin, and echocardiogram showing apical hypokinesis with basal hypercontractility — is classic for **Takotsubo (stress) cardiomyopathy**, which can be triggered by intense physical or emotional stress.  \n\nIn Takotsubo cardiomyopathy, the most feared acute complication is **ventricular arrhythmia recurrence**, which is often due to QT prolongation that can develop in the first 48–72 hours.  \nThe most critical next step to prevent recurrence of cardiac arrest here is to **avoid drugs that prolong the QT interval** and to **start a beta-blocker**, which can reduce catecholamine-driven myocardial stunning and lower arrhythmia risk.  \n\n- **A** (Immediate coronary angiography) — not the most critical here, as the clinical picture strongly points to Takotsubo rather than acute coronary occlusion in a 16-year-old with no risk factors.  \n- **B** (IV beta-blocker) — correct, as it addresses the underlying sympathetic surge and reduces arrhythmia risk.  \n- **C** (Wearable cardioverter-defibrillator) — may be considered later if severe LV dysfunction persists, but not the most critical immediate step.  \n- **D** (IVIG) — not indicated; this is for conditions like myocarditis or Kawasaki disease, not Takotsubo.  \n- **E** (IV calcium gluconate) — not indicated here; used for hyperkalemia or calcium channel blocker overdose.  \n\nThe answer is B.  \n\n**The answer is (B)**"}]